您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Plant-originated and CTM Anticancer Drugs Report

讯：

Research Report on Chinese Market of Plant-originated and CTM
 Anticancer Drugs

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$2,700 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
//m.limatoxi.com

Table of contents
1 Categories and action mechanism of anticancer drugs
  1.1 Categories of main anticancer drugs
  1.2 Summary of action mechanism
2 Market analysis of anticancer drugs
  2.1 Market scale and growth trend
    2.1.1 Theoretical market scale 
    2.1.2 Growth trend
  2.2 Market shares of different categories
  2.3 Market shares of different breeds
  2.4 Leading manufacturing enterprises and sales value
  2.5 Prospect of main breeds
3 Individual share of chemical drugs, Plant-originated drugs and Chines
 traditional  medicine(TCM)
4 Market sructure of plant-originated anticancer drugs
  4.1 Growth trend and structure of breeds
  4.2 Analysis about key breeds
      Paclitaxel
      Docetaxel
      Vinorelbine
      hydroxycamptothecin
5 Market sructure of Chines traditional medicine(TCM) anticancer drugs
  5.1 Categories
  5.2 Sales analysis of TCM adjunct anticancer drugs
  5.3 Sales analysis of TCM anticancer drugs
  5.4 TCM for cancer pain
6 Domestic major research direction is plant active ingredients